142 related articles for article (PubMed ID: 29196036)
1. Severe myopericarditis following induction therapy with idarubicin and transretinoic acid in a patient with acute promyelocytic leukemia.
Carcelero San Martín E; Riu Viladoms G; Creus Baró N
Med Clin (Barc); 2018 Jun; 150(12):492-493. PubMed ID: 29196036
[No Abstract] [Full Text] [Related]
2. A case of ATRA-induced isolated myocarditis in the absence of circulating malignant cells: demonstration of the t(15;17) translocation in the inflammatory infiltrate by in situ hybridisation.
van Rijssel RH; Wegman J; Oud ME; Pals ST; van Oers MH
Leuk Res; 2010 Jul; 34(7):e142-4. PubMed ID: 20060166
[No Abstract] [Full Text] [Related]
3. Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
Dang CC; Guan YK; Lau NS; Chan SY
J Oncol Pharm Pract; 2020 Dec; 26(8):2034-2037. PubMed ID: 32279594
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
5. Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA).
Klein SK; Biemond BJ; van Oers MH
Ann Hematol; 2007 Dec; 86(12):917-8. PubMed ID: 17619879
[No Abstract] [Full Text] [Related]
6. Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia.
Strocchio L; Gurnari C; Santoro N; Putti MC; Micalizzi C; Zecca M; Cuccurullo R; Girardi K; Diverio D; Testi AM; Lo-Coco F; Locatelli F
Br J Haematol; 2019 Apr; 185(2):360-363. PubMed ID: 30028005
[No Abstract] [Full Text] [Related]
7. First reported case of aplastic anemia occurring in a patient after acute promyelocytic leukemia in remission.
Pham A; Bahadini B; Alsabeh R; Steinberg A
Clin Adv Hematol Oncol; 2009 Oct; 7(10):670-4. PubMed ID: 20040907
[No Abstract] [Full Text] [Related]
8. All-trans retinoic acid-induced myositis.
Kannan K; Khan HA; Jain R; Hussein SS; Dennison D
Br J Haematol; 2005 Dec; 131(5):560. PubMed ID: 16351631
[No Abstract] [Full Text] [Related]
9. Anthracycline-induced acute myocarditis and ventricular fibrillation arrest.
Pallazola VA; Murray JC; Al Harthy M; Zimmerman SL; Webster J; Gondek LP
Am J Hematol; 2018 Mar; 93(3):469-470. PubMed ID: 29194712
[No Abstract] [Full Text] [Related]
10. sQuiz your knowledge: Generalized lesions resembling water droplets after treatment with idarubicin and all-trans retinoic acid.
Arjona-Aguilera C; Rodríguez CC; Jiménez-Gallo D
Eur J Dermatol; 2016 Jun; 26(3):329-31. PubMed ID: 27328664
[No Abstract] [Full Text] [Related]
11. Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
Parajuli R; Altman J; Kuzel T; Perdekamp M; Tallman M
Am J Hematol; 2010 Oct; 85(10):829. PubMed ID: 20721888
[No Abstract] [Full Text] [Related]
12. Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia.
Bseiso AW; Kantarjian H; Estey E
Leukemia; 1997 Jan; 11(1):168-9. PubMed ID: 9001434
[TBL] [Abstract][Full Text] [Related]
13. Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review.
Rhee JY; Tremblay D; Chan AM; Tallman MS; Mascarenhas J
Blood Adv; 2019 Jun; 3(12):1854-1857. PubMed ID: 31213431
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy.
Serefhanoglu S; Buyukasik Y; Goker H; Sayinalp N; Haznedaroglu IC; Aksu S; Ozcebe OI; Turgut M; Aslan R; Ozdemir E
Leuk Res; 2010 Dec; 34(12):e317-9. PubMed ID: 20696473
[No Abstract] [Full Text] [Related]
15. Recurrent acute myopericarditis without effusion during ATRA induction and ATO salvage of APL: a variant form of the differentiation syndrome?
Vassilakopoulos TP; Asimakopoulos JV; Plata E; Kelepesis G; Petevi K; Koutsi C; Papageorgiou L; Tsaftaridis P; Angelopoulou MK; Konstantopoulos K; Meletis J
Leuk Lymphoma; 2017 Jul; 58(7):1743-1746. PubMed ID: 27919176
[No Abstract] [Full Text] [Related]
16. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H
Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to arsenic trioxide combined with all-trans-retinoic acid in children with acute promyelocytic leukaemia in France.
Garcia Spezza E; Brethon B; Petit A; Mazingue F; Gandemer V; Boissel N; Carausu L; Reguerre Y; Leverger G; Ducassou S
Br J Haematol; 2020 Jan; 188(1):170-173. PubMed ID: 31808943
[No Abstract] [Full Text] [Related]
18. High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA.
Aljurf M; Al Qurashi F; Al Mohareb F; Sahovic E; Al Sharif F; Al Zahrani H; Al Shanqeeti A; Owaidah T; Iqbal A; Zaidi SZ; Nurgat ZA; Sanz M; Chaudhri N
Med Oncol; 2010 Sep; 27(3):702-7. PubMed ID: 19669610
[TBL] [Abstract][Full Text] [Related]
19. Is There Still a Role for Low-Dose All-Transretinoic Acid in the Treatment of Acute Promyelocytic Leukemia in the Arsenic Trioxide Era?
Jaime-Pérez JC; González-Leal XJ; Pinzón-Uresti MA; Gómez-De León A; Cantú-Rodríguez OG; Gutiérrez-Aguirre H; Gómez-Almaguer D
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):816-9. PubMed ID: 26500134
[TBL] [Abstract][Full Text] [Related]
20. Lung injury caused by all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.
Ariza-Prota M; Pando-Sandoval A; García-Clemente M
Arch Bronconeumol; 2016 Aug; 52(8):441-2. PubMed ID: 26915524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
